|
Liver disease Articles
Liver disease News : Fatty Liver Disease Ups Heart Risks for Obese Kids Mon, 30 Jun 2008 21:02:02 GMT MONDAY, June 30 (HealthDay News) -- More than 6 million children in the United States have a condition called nonalcoholic fatty liver disease (NAFLD), which can boost their odds for heart disease, researchers report.Liver disease News : Fatty Liver Disease May Raise Heart Disease Risk In Overweight, Obese Kids Tue, 01 Jul 2008 15:14:00 GMT A fatty liver disease that is not well-known in overweight and obese children may be a precursor of cardiovascular disease, researchers reported in Circulation: Journal of the American Heart Association. Researchers performed a case-controlled study of 150 overweight children with biopsy-proven non-alcoholic fatty liver disease (NAFLD) and 150 overweight children without NAFLD.Fatty Liver Disease May Raise Heart Disease Risk In Overweight, Obese Kids Tue, 01 Jul 2008 03:21:52 GMT Pediatric non-alcoholic fatty liver disease (NAFLD) raises cardiovascular risk in overweight and obese children. More than 6 million children in the United States have the fatty liver disease. NAFLD is most prevalent in children and adolescents of Hispanic and Asian ethnicity. Researchers suggest all obese children and those with symptoms of metabolic syndrome be screened for NAFLD. Fatty Liver Disease Ups Heart Risks for Obese Kids Mon, 30 Jun 2008 23:17:45 GMT Copyright © 2008 ScoutNews LLC. All rights reserved. MONDAY, June 30 (HealthDay News) -- More than 6 million children in the United States have a condition called nonalcoholic fatty liver disease (NAFLD), which can boost their odds for heart disease, researchers report.Fatty Liver Disease Ups Kids' Heart Risk Mon, 30 Jun 2008 20:12:13 GMT A new study shows non-alcoholic fatty liver disease is associated with more serious heart disease risk factors in overweight and obese children.Fatty liver disease may increase heart disease risk in overweight, obese kids Tue, 01 Jul 2008 10:07:40 GMT Washington, July 1 : Overweight or obese kids with fatty liver disease might be at an increased risk of developing heart disease in later life, suggests a new study.Fatty liver disease may raise heart disease risk in overweight, obese kids Tue, 01 Jul 2008 01:00:33 GMT A fatty liver disease that is not well-known in overweight and obese children may be a precursor of cardiovascular disease, researchers reported in Circulation: Journal of the American Heart Association.Affymetrix Technology Used To Discover Molecular Mechanisms Of Liver Disease Thu, 03 Jul 2008 12:14:52 GMT Affymetrix Inc. (Nasdaq:AFFX) announced that a team of researchers at the Fraunhofer Institute in Germany is using Affymetrix' Whole Transcript (WT) gene expression technology to better understand the molecular basis of drug-induced liver injury (DILI).YOU ARE HERE: Thu, 03 Jul 2008 13:28:31 GMT Patients treated with antiretroviral therapy have a high prevalence of fatty liver disease, according to an Italian study published in the July 15 th edition of the Journal of Infectious Diseases . The overall prevalence of the condition amongst individuals in the study was 37%. None of these individuals had hepatitis B or C infection, drank excessively or were drug users.Fatty Liver Disease Ups Heart Risks for Obese Kids Tue, 01 Jul 2008 00:32:21 GMT As many as 6 million U.S. youngsters have the condition, researchers warn.Fatty liver in kids tied to metabolic syndrome Mon, 30 Jun 2008 20:20:16 GMT In overweight or obese children, fatty liver disease appears to be a specific risk factor for the metabolic syndrome, a precursor of heart disease and diabetes, according to a study appearing in the American Heart Association's journal Circulation.Affymetrix Technology Used to Discover Molecular Mechanisms of Liver Disease Mon, 30 Jun 2008 13:01:23 GMT Affymetrix Inc. (Nasdaq:AFFX) today announced that a team of researchers at the Fraunhofer Institute in Germany is using Affymetrix' Whole Transcript (WT) gene expression technology to better understand the molecular basis of drug-induced liver injury (DILI). The ultimate goal of the project is to develop a diagnostic array that can detect signals of liver toxicity earlier and more accurately ...Fatty liver disease may raise heart disease risk in overweight, obese kids Mon, 30 Jun 2008 20:09:36 GMT NAFLD in overweight children is strongly associated with metabolic syndrome. The association is independent of both body mass index and insulin sensitivity.Affymetrix Technology Used to Discover Molecular Mechanisms of Liver Disease Mon, 30 Jun 2008 12:00:00 GMT SANTA CLARA, Calif.----Affymetrix Inc. today announced that a team of researchers at the Fraunhofer Institute in Germany is using Affymetrix’ Whole Transcript gene expression technology to better understand the molecular basis of drug-induced liver injury .Report highlights alcohol dangers Thu, 03 Jul 2008 20:40:40 GMT About 750,000 people between the ages of 16 and 65 are "hazardous" drinkers, a new report says.Children Must Be Protected Against Hepatitis, Warns ABPI Thu, 03 Jul 2008 09:13:01 GMT Children should be vaccinated against hepatitis to prevent the spread of medicine-resistant strains of the disease, according to a report published by The Association of The British Pharmaceutical Industry (ABPI).Fourth Annual Symposium On Liver-Directed Microsphere Therapy Raises Awareness Of The Latest Advances For Treating ... Thu, 03 Jul 2008 12:15:52 GMT More than 170 physicians and health care professionals specializing in the treatment of liver metastases gathered May 2-3 in Chicago for the fourth annual clinical symposium on liver-directed microsphere therapy. The symposium, sponsored by the Goshen Center for Cancer Care, was supported by an educational grant provided by Sirtex Medical.Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites Thu, 03 Jul 2008 11:09:29 GMT Turnhout, Belgium (ots/PRNewswire) - Movetis NV, a European specialist pharmaceutical company, today announced that M0002 is progressing to phase IIb ...Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites Thu, 03 Jul 2008 11:06:21 GMT Turnhout, Belgium (ots/PRNewswire) - Movetis NV, a European specialist pharmaceutical company, today announced that M0002 is progressing to phase IIb following positive results of a phase IIa multiple-dosing trial for the treatment of ...Report: 8 Valley Counties Unhealthiest In Calif. Wed, 02 Jul 2008 23:31:55 GMT A study rated California counties on several factors, including air quality, fitness, access to healthcare and safe playgrounds. Among the 10 counties scoring the worst, eight are in the Valley.Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites Thu, 03 Jul 2008 10:42:00 GMT Movetis NV, a European specialist pharmaceutical company, today announced that M0002 is progressing to phase IIb following positive results of a phase IIa multiple-dosing trial for the treatment of ascites, the accumulation of fluid in the abdomen in patients with liver cirrhosis resulting from liver conditions such as hepatitis C, hepatitis B or alcoholism.Stanislaus civil grand jury: Needle exchange could curb HIV, hepatitis C Wed, 02 Jul 2008 14:13:07 GMT Stanislaus County should create a needle exchange program to reverse a trend of rising hepatitis C infections, the civil grand jury recommended Monday.Datebook for July 2 Wed, 02 Jul 2008 13:11:57 GMT SATURDAYYoung woman gives part of her liver to save a friend Wed, 02 Jul 2008 12:08:39 GMT Shikha Chandok gave two-thirds of her liver to a family friend who, without it, would have died. That was last December. Recently, at a ceremony at Toronto General Hospital, the 22-year-old Mississauga woman and her friend Sunila Sharma reflected on events of the past six months. Diabetes: Underrated, insidious and deadly Tue, 01 Jul 2008 11:24:06 GMT Vision, hearing, sexual function — you name it, diabetes harms it.Split Liver Transplantation Examined As Viable Solution To Organ Shortages Tue, 01 Jul 2008 11:13:32 GMT Can split liver transplantation reliably yield grafts for two adults? Experts consider this question alongside new findings about the procedure in the July issue of Liver Transplantation, a journal by John Wiley & Sons. The articles are also available online at Wiley Interscience (http://www.interscience.wiley.com/).Fatty liver may raise heart disease risk in obese kids Tue, 01 Jul 2008 07:49:24 GMT Washington, July 1: Fatty liver in overweight or obese children might be a precursor of cardiovascular disease, says a new study.Diabetes: Underrated, Insidious and Deadly Tue, 01 Jul 2008 09:46:42 GMT Vision, hearing, sexual function — you name it, diabetes harms it.Entertainment Tue, 01 Jul 2008 05:56:01 GMT A new study just published in the Annals of Internal Medicine suggests that people who regularly indulge in coffee may live longer than those who don't.Alkermes Initiates Phase 3 Clinical Study Of VIVITROL(R) For The Treatment Of Opioid Dependence Tue, 01 Jul 2008 08:13:22 GMT Alkermes, Inc. (NASDAQ: ALKS) announced the initiation of a phase 3 clinical trial of VIVITROL® (naltrexone for extended-release injectable suspension) for the treatment of opioid dependence. The multi-center study is designed to assess the efficacy and safety of VIVITROL in approximately 200 patients diagnosed with opioid dependence.Business developments in the San Fernando Valley area Tue, 01 Jul 2008 07:04:57 GMT Lil Lepore and Shari Frazier: The owners of Vino 100 Valencia were named Entrepreneurs of the Year by the San Fernando Valley Business Journal at its annual Women In Business event.Simple solution to a deadly problem Mon, 30 Jun 2008 23:42:16 GMT Pneumococcal disease causes serious bacterial infections in children. Every year, thousands of children below five die from it yet these deaths are avoidable. NUR UMIRRA MOHD SAHAD writes about pneumococcal disease and the safeguard against it.Health Matters Tue, 01 Jul 2008 05:15:55 GMT I Can Cope Online Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO(R) Mon, 30 Jun 2008 17:12:41 GMT Celsion Corporation (NASDAQ: CLN) announced that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO® conference.Dealing With 100 Degree Temperatures Mon, 30 Jun 2008 22:14:09 GMT Extreme heat is the number one weather-related killer. The CBS 11 Storm Team expects the temperature to be at or above 100 degrees over the next few days. Follow these tips on how to deal with this high heat.  Get Your Custom Forecast Health Happenings Mon, 30 Jun 2008 20:41:21 GMT A support group for people with diabetes and their families will meet 6:30 p.m. July 28 in the Austin Room, Room 202, of the Medical Office Building at North Hills Hospital, 4401 Booth Calloway Road in North Richland Hills. Call 817-255-1664. The group meets on the fourth Monday of each month with various speakers and topics. For more information call 817-922-1061 or 817-255-1046. "The Talk," ...Safer, More Efficient Medication For Hepatitis B Treatment Mon, 30 Jun 2008 08:12:32 GMT Patients with hepatitis B who did not respond to lamivudine therapy had a better virological response after switching to entecavir for a year.Diagnostic HYBRIDS Receives Third Frontier Grant For Development Of Assays To Monitor Drug Resistance And Vaccine ... Mon, 30 Jun 2008 10:12:52 GMT Diagnostic HYBRIDS has received funding through the Biomedical Research Commercialization Program (BRCP) to develop more sensitive and affordable assays for the monitoring of patients infected with Human Immunodeficiency Virus (HIV) and/or Hepatitis C Virus (HCV) and to produce vaccines against influenza virus.Pharming acquires sub-license to key fibrinogen patents from GTC Mon, 30 Jun 2008 05:46:39 GMT Biotech company, Pharming Group NV has acquired an exclusive sub-license to key patents and technology on recombinant fibrinogen from GTC Biotherapeutics Inc ('GTC').There's reason to enjoy your morning coffee Mon, 30 Jun 2008 07:19:16 GMT Ever feel guilty when you drink that morning cup-o-joe? Well, here's a reason to enjoy your coffee instead.Songwriter Edward Struzick, 57, dies at his home Fri, 27 Jun 2008 08:44:02 GMT Edward Struzick, prolific songwriter who became an integral part of the Muscle Shoals music scene, died Wednesday. He was 57.Struzick died at his Sheffield home from complications from liver disease, said his wife, Judy.As memory and ability fade with advancing Alzheimer's, the disease turns its sufferers into fragile husks. With ... Mon, 30 Jun 2008 04:09:07 GMT Everyone knows one thing about Alzheimer's disease: They dread the thought of getting it.Ulcerative Colitis Sat, 28 Jun 2008 20:25:07 GMT Confronting a new diagnosis can be frightening, and because research changes so often, confusing. Here are some questions you may not think to ask your doctor, along with notes on why they are important.ThermoDox In Combination With Radio Frequency Ablation Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO Sun, 29 Jun 2008 09:13:32 GMT Celsion Corporation (NASDAQ: CLN) announced today that the interim results from its second Phase I liver cancer confirmation study of ThermoDox in combination with Radio Frequency Ablation (RFA) treating patients with primary and metastatic liver cancer were presented at both Oral and Poster presentation at the WCIO 2008 and Best of ASCO® conference.Integrative Way: Study brews up good reasons to pour a cup of coffee Sun, 29 Jun 2008 07:18:55 GMT Ever feel guilty when you drink that morning cup o' joe? Well, here's a reason to enjoy your coffee.European CHMP Issues Positive Opinion On Cymbalta For The Treatment Of Generalised Anxiety Disorder Sun, 29 Jun 2008 08:13:52 GMT Eli Lilly and Co (NYSE: LLY) and Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion supporting the approval of Cymbalta® (duloxetine hydrochloride) for the treatment of Generalised Anxiety Disorder (GAD).Sorafenib, First Pharmaceutical Drug To Improve Survival Amongst Patients With Advanced Hepatocarcinoma Sat, 28 Jun 2008 08:15:33 GMT International research involving the University Hospital of the University of Navarra, together with other hospitals in Spain, has shown that Sorafenib, an orally administered pharmaceutical medicine, results in patients with primary hepatocarcinomas (liver tumours) to live 40% more on average compared to those not taking the drug.Post office closure threatens child's drug treatment Sat, 28 Jun 2008 09:38:32 GMT THE family of a five-year-old girl who depends on parcels of life-saving medicine sent to her local post office have spoken out against the controversial programme of branch closures.Statue drive on a wave Sat, 28 Jun 2008 07:14:01 GMT Pier Plaza event will raise funds to sculpt surfer Dewey Weber. |
Infectious and parasitic diseases |
|
|
< Home > |
||